DRAM Market Poised for Steady Growth in 2022
DRAM makers posted a small 6% Q/Q revenue decline in Q4, but gave an outlook for solid 2022 growth after growing 41% in 2021. This seems to be a...
287 Views
FnGuide TIGER Top 10 Rebalancing: LG Energy IN & Celltrion OUT
This post previews the upcoming rebalancing of the FnGuide Top 10 Index (TIGER ETF, KS 292150), whose AUM currently amounts to ₩1T. At this point,...
280 Views
Vedant Fashions IPO - Dominant Position in a Small Niche but Appears Pricey
Vedant Fashions is looking to raise up to US$420m in its India IPO. In this note we will talk about the company background and run the deal through...
222 Views
Samsung Biologics: Rights Offering of 3 Trillion Won to Acquire Remaining Stake in Samsung Bioepsis
Despite the long-term positive prospects of consolidating results from Samsung Bioepsis, we believe the acquisition price was a bit too high at...
419 Views
Samsung Biologics Offering: Deal Summary & Trading Dynamics
Samsung Biologics announced that it would purchase all of Samsung Bioepis shares owned by Biogen. So, it also announced a ₩3T rights offering. This...
356 Views